(Q37900473)

25 August 2017

1 reference

title

Neuropathy in prediabetes: does the clock start ticking early? (English)

1 reference

25 August 2017

Nikolaos Papanas

1

1 reference

25 August 2017

Aaron I Vinik

series ordinal

2

1 reference

25 August 2017

Dan Ziegler

series ordinal

3

1 reference

25 August 2017

publication date

12 July 2011

1 reference

Nature Reviews Endocrinology

25 August 2017

published in

1 reference

25 August 2017

volume

7

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

682-690

1 reference

Diabetes prevalence in England, 2001--estimates from an epidemiological model

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetic cardiovascular autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Idiopathic neuropathy, prediabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Impaired glucose tolerance and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Painful sensory polyneuropathy associated with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

The spectrum of neuropathy in diabetes and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Report of the expert committee on the diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Sensory function and albumin excretion according to diagnostic criteria for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Lifestyle intervention for pre-diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Impaired glucose tolerance--does it cause neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetic neuropathy in Mauritius: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Glucose regulation and chronic pain at multiple sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Chronic pain, impaired glucose tolerance and diabetes: a community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality: evidence for distinct pathways: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Epidemiological evidence of altered cardiac autonomic function in overweight but not underweight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Mechanism of diabetic neuropathy: Where are we now and where to go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetic neuropathy--a continuing enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Early diabetic neuropathy: triggers and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Neurons undergo apoptosis in animal and cell culture models of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetes regulates mitochondrial biogenesis and fission in mouse neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

What does postprandial hyperglycaemia mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Vascular risk factors and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Hyperlipidemia: a new therapeutic target for diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Prevalence of somatic small fiber neuropathy in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Idiopathic neuropathy patients are at high risk for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Small fiber neuropathy is associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Microvascular complications of impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Impaired glucose tolerance and metabolic syndrome in idiopathic polyneuropathy: the role of pain and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Assessment of neuropathic pain in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Review: small-fiber neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Surrogate markers of small fiber damage in human diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Electrophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Clinical and electrophysiological correlations in type 2 diabetes mellitus at diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Peripheral neuropathy with impaired glucose tolerance: a sweet smell of success?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Impaired glucose tolerance is associated with postganglionic sudomotor impairment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Exploration of small fibers for testing diabetic neuropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

A rational diagnostic approach to peripheral neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Utility of skin biopsy to evaluate peripheral neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.113

Cardiac autonomic neuropathy in patients with uraemia is not related to pre-diabetes.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21750507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence of diabetes and impaired fasting glucose in adults--United States, 1999-2000.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21750507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2011.113

1 reference

25 August 2017

1 reference